Koyfin Home > Directory > Health Care > Arcus Biosciences Inc > Gross Margin

Arcus Biosciences Inc Gross Margin Chart (RCUS)

Arcus Biosciences Inc annual/quarterly Gross Margin from 2017 to 2018. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • Arcus Biosciences Inc Gross Margin for the quarter ending December 12, 2018 was $2,546m a 96.07% increase of 2,446m year over year
  • Arcus Biosciences Inc Gross Margin for the last 12 months ending December 12, 2018 was $100m
Other Margins & Efficiency Metrics:
  • Arcus Biosciences Inc EBITDA Margin for the quarter ending September 09, 2018 was $-260m
  • Arcus Biosciences Inc Return on Capital % for the quarter ending December 12, 2018 was -14.04
  • Arcus Biosciences Inc Return on Equity % for the quarter ending December 12, 2018 was -20.49
View Chart On Koyfin

Quarterly RCUS Gross Margin Data

12/2018$2,546m
09/2018$-200m
12/2017$2,906m
09/2017$100m

Annual RCUS Gross Margin Data

2018$100m